3647 results for «604»
3647 results
CathWorks FFRangio - Enhancing patient care
16 May 2024 – From EuroPCR 2024
Explore this EuroPCR 2024 session to gain an in-depth understanding of how FFRangio utilizes routine angiograms to provide valuable insights, delve into the integration of FFRangio-guided decisions for optimizing patient care, and examine the practical application of FFRangio in routine clinical practice, encompassing its benefits and challenges.
Tough calls during complex PCI
14 May 2024 – From EuroPCR 2024
This joint session with India Live focuses on understanding the reasons for potential failures during complex PCI and strategies to overcome them. It features case presentations and discussions on successfully managing challenging scenarios, including cases where the operator had previously failed, as well as cases where...
Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, focuses on understanding different approaches and techniques for managing challenging situations and complications in patients with ACS and acute heart failure undergoing PCI. It covers the prompt recognition of potential periprocedural complications, various management strategies for PCI...
Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...
Which AF patients may benefit from LAA closure?
02 Jul 2026
Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
